Findings support the ongoing Phase 1 clinical development of BBI-940, an oral, selective kinesin degrader, as a potential first-in-class therapy for select advanced or metastatic breast cancers ...
New protocol generated glucose-responsive SC-islets from eight hPSC lines tested, demonstrating potential for autologous ...
Researchers at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed an improved method for ...
Complete the form below to download the infographic. Cell-line development (CLD) is crucial for generating therapeutic ...
Biologics now encompass a wide range of therapeutic solutions from IVF to vaccines. What makes such technologies possible in ...
A new platform for studying mtDNA mutations implicated in human disease could help accelerate treatments for mitochondrial ...
By examining genetic clues that linger in adult cells, scientists have now gained surprising insights into the developmental ...
This webinar explores an integrated approach to mAb development that embeds manufacturability, scalability, lifecycle ...
Pivotal findings for the off-the-shelf cell therapy surpassed William Blair’s expectations and sent Allogene Therapeutics’ stock up more than 50% in pre-market trading Monday morning.
Alstom has announced the acquisition of hydrogen fuel cell activities from Cummins for hydrogen-powered train fleets.
Sartorius announces the launch of the CellCelector CLD, an automated imaging and cell isolation platform designed to simplify ...
Scientist who established productive growth of HIV in an immortalised cell line, which led to the development of the UK’s first antibody test for the virus ...